Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic
Research Reports in Clinical Cardiology · 2016
DOI: 10.2147/rrcc.s103537 ↗Kurz gefasst
Leitlinie in der Zeitschrift Research Reports in Clinical Cardiology, 2016. Verfasst von Michael Heffernan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Heffernan, M. (2016). Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic. Research Reports in Clinical Cardiology. https://doi.org/10.2147/rrcc.s103537
Vancouver
Heffernan M. Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic. Research Reports in Clinical Cardiology. 2016. doi:10.2147/rrcc.s103537
BibTeX
@article{Heffernan2016,
author = {Heffernan, Michael},
title = {Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic},
journal = {Research Reports in Clinical Cardiology},
year = {2016},
doi = {10.2147/rrcc.s103537}
}
EUVIMED